Company / Revenue per Share
Zenas BioPharma, Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.24
FY2025
5-year range
$0.24 / $32.65
FY2023-FY2025
Trend
-99.2%
vs FY2024
Sector context
#126 of 154
Health Care
What the data says
Zenas BioPharma, Inc.'s revenue per share of $0.24 is lower than 82% of companies in the Health Care sector (FY2025). Declined from $32.65 to $0.24 over the past 2 years.
Based on SEC 10-K filings.
0.24 in FY2025.
Declined from $32.65 to $0.24 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 154This company $0.24 Sector average $15.09
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 99.2% year-over-year.
- Ranks #126 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.24 | -99.2% |
| FY2024 | $31.71 | -2.9% |
| FY2023 | $32.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026